Scl Science Inc. (246960)
Market Closed
11 Aug, 06:30
KRX SM KRX SM Primary ₩
1,945. 00
+111
+6.0523%
₩
75.75B Market Cap
- P/E Ratio
- Div Yield
141,991 Volume
- Eps
₩ 1,834
Previous Close Want to track 246960 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
246960 closed today higher at ₩1,945, an increase of 6.0523% from yesterday's close, completing a monthly increase of 11.2064% or ₩196. Over the past 12 months, 246960 stock lost -20.6122%.
246960 is not paying dividends to its shareholders.
Scl Science Inc. has completed 1 stock splits, with the recent split occurring on Jun 30, 2025.
The company's stock is traded on one exchange.
Scl Science Inc. (246960) FAQ
What is the stock price today?
The current price is ₩1,945.00.
On which exchange is it traded?
Scl Science Inc. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 246960.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 75.75B.
Has Scl Science Inc. ever had a stock split?
Scl Science Inc. had 1 splits and the recent split was on Jun 30, 2025.
Scl Science Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Dr. Moon Sue Lee CEO | KRX SM Exchange | - ISIN |
| KR Country | 44 Employees | - Last Dividend | 30 Jun 2025 Last Split | - IPO Date |
Overview
SCL Science Inc., originally operating under the name InnoTherapy, Inc., is a South Korean company that focuses on the development and commercialization of medical sealant products. With a dedication to innovation in the medical field, the company offers a variety of products designed to improve patient outcomes in surgical and wound care scenarios. Since its inception in 2010, SCL Science Inc. has established itself as a key player in the medical supplies industry, providing solutions that cater to the needs of both healthcare providers and patients alike. Its corporate headquarters are located in Seoul, South Korea, reflecting its strong roots and commitment to contributing to the advancement of medical technology in the region.
Products and Services
- InnoSEAL: This product is an externally applied hemostatic agent designed to control bleeding effectively. It is indicative of the company's commitment to producing innovative solutions for acute care in medical settings.
- InnoSEAL Plus: As an absorbable hemostatic pad, InnoSEAL Plus further extends the company's offerings in the domain of bleeding control, offering a versatile solution for various surgical contexts.
- EndoSil: This absorbable hemostatic agent is specially formulated for use in managing gastrointestinal oozing bleeding. Its development underscores SCL Science Inc.'s focus on addressing specific medical challenges through targeted solutions.
- GellySil: GellySil stands as a proprietary biomaterial, highlighting the company's investment in research and development to create unique, high-quality products that meet specific medical needs.
- Film-type Surgical Sealant: This product is designed for the complete sealing of anastomosis sites, showcasing the company's dedication to improving post-surgical recovery and outcomes through innovative sealant technologies.
- STOP Needle: The STOP needle represents a self-sealing solution for general and ophthalmic use, illustrating the company's broad approach to product development and its contribution to safer medical procedures.
- Wound Dressing: Developed for chronic wounds, burns, and other similar conditions, this product category emphasizes SCL Science Inc.'s commitment to improving wound care and management through advanced material science.
- Gene Therapy Delivery System: This bio-therapeutics delivery system signifies the company's forward-looking approach, venturing into the burgeoning field of gene therapy with innovative delivery solutions.
Contact Information
Address: #401, ACE Hitech City 2
Phone: 82 2 6959 1338
Website: https://www.innotherapy.com
